In last trading session, Tenaya Therapeutics Inc (NASDAQ:TNYA) saw 2.23 million shares changing hands with its beta currently measuring 2.86. Company’s recent per share price level of $0.39 trading at $0.0 or -1.65% at ring of the bell on the day assigns it a market valuation of $63.10M. That closing price of TNYA’s stock is at a discount of -1125.64% from its 52-week high price of $4.78 and is indicating a premium of 7.69% from its 52-week low price of $0.36. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.59 million shares which gives us an average trading volume of 3.50 million if we extend that period to 3-months.
For Tenaya Therapeutics Inc (TNYA), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1.00. Splitting up the data highlights that, out of 3 analysts covering the stock, 0 rated the stock as a Sell while 0 recommended an Overweight rating for the stock. 0 suggested the stock as a Hold whereas 3 see the stock as a Buy. 0 analyst(s) advised it as an Underweight.
Tenaya Therapeutics Inc (NASDAQ:TNYA) trade information
Upright in the red during last session for losing -1.65%, in the last five days TNYA remained trading in the red while hitting it’s week-highest on Thursday, 05/08/25 when the stock touched $0.39 price level, adding 15.22% to its value on the day. Tenaya Therapeutics Inc’s shares saw a change of -72.87% in year-to-date performance and have moved -13.78% in past 5-day. Tenaya Therapeutics Inc (NASDAQ:TNYA) showed a performance of -20.84% in past 30-days. Number of shares sold short was 8.73 million shares which calculate 3.68 days to cover the short interests.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -15.48% during past 5 years.
Tenaya Therapeutics Inc (NASDAQ:TNYA)’s Major holders
Insiders are in possession of 0.72% of company’s total shares while institution are holding 61.27 percent of that, with stock having share float percentage of 61.72%. Investors also watch the number of corporate investors in a company very closely, which is 61.27% institutions for Tenaya Therapeutics Inc that are currently holding shares of the company. COLUMN GROUP LLC is the top institutional holder at TNYA for having 9.4 million shares of worth $29.14 million. And as of 2024-06-30, it was holding 10.968 of the company’s outstanding shares.
The second largest institutional holder is RA CAPITAL MANAGEMENT, L.P., which was holding about 7.62 million shares on 2024-06-30. The number of shares represents firm’s hold over 8.8935 of outstanding shares, having a total worth of $23.63 million.
On the other hand, VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF are the top two Mutual Funds which own company’s shares. As of Dec 31, 2024 , the former fund manager was holding 2.06 shares of worth $0.8 million or 1.27% of the total outstanding shares. The later fund manager was in possession of 1.46 shares on Mar 31, 2025 , making its stake of worth around $0.56 million in the company or a holder of 0.90% of company’s stock.
